CAR-TCR 2023 – Matt Lakelin
Innovative, advanced therapies have enormous promise, but also come with a host of logistical problems that innovators underestimate at their own peril.
At CAR-TCR in Boston last month, pharmaphorum’s Jonah Comstock caught up with Matt Lakelin, co-founder of TrakCel, a software company that helps makers of advanced therapies manage their supply chain.
In this wide-ranging conversation, Lakelin shares some insights from TrakCel’s more than a decade of operation. He emphasises the importance of collaboration in this developing field, and learning from one another’s successes and failures.
The two also discuss some of the unique challenges cell therapies, especially autologous ones, face when it comes to running clinical trials, and also touch on the importance of patient engagement as a North Star and the far future of CAR-T as a frontline treatment - potentially mitigating some of the negative aspects of standard of care treatments, like chemotherapy.
Tune in to the video below to hear some insights about the CAR-T space from a long-time veteran.
